Hypertension and hyperlipidaemia have high prevalence among diabetics and increase patients’ risk of cardiovascular diseases, ultimately affecting prognosis negatively. Medicine claims data have gained prominence in the study of drug‐related… Click to show full abstract
Hypertension and hyperlipidaemia have high prevalence among diabetics and increase patients’ risk of cardiovascular diseases, ultimately affecting prognosis negatively. Medicine claims data have gained prominence in the study of drug‐related events and outcomes. There is paucity of publications on the time‐to‐onset of treatment for these conditions among South African diabetics using secondary data. This study aims to determine the time‐to‐onset of treatment for hypertension and hyperlipidaemia among diabetics using a South African medicine claims data.
               
Click one of the above tabs to view related content.